These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11407226)

  • 41. CRTH2 antagonists in the treatment of allergic responses involving TH2 cells, basophils, and eosinophils.
    Townley RG; Agrawal S
    Ann Allergy Asthma Immunol; 2012 Dec; 109(6):365-74. PubMed ID: 23176872
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of an orally active Th1/Th2 balance modulator, M50367, on IgE production, eosinophilia, and airway hyperresponsiveness in mice.
    Kato Y; Manabe T; Tanaka Y; Mochizuki H
    J Immunol; 1999 Jun; 162(12):7470-9. PubMed ID: 10358202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels.
    Hofstra CL; Van Ark I; Hofman G; Kool M; Nijkamp FP; Van Oosterhout AJ
    J Immunol; 1998 Nov; 161(9):5054-60. PubMed ID: 9794443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attainments in atop: special aspects of allergy and IgE.
    Milgrom H
    Adv Pediatr; 2002; 49():273-97. PubMed ID: 12214775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cytokines and anti-cytokines in allergic diseases].
    Fal AM
    Pol Merkur Lekarski; 2003 Jun; 14(84):613-6. PubMed ID: 14524284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of histamine on Th1/Th2 cytokine balance.
    Packard KA; Khan MM
    Int Immunopharmacol; 2003 Jul; 3(7):909-20. PubMed ID: 12810348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of the Th1/Th2 bias by an immunoglobulin histamine complex in the ovalbumin allergy mouse model.
    Ayoub M; Lallouette P; Sütterlin BW; Bessler WG; Huber M; Mittenbühler K
    Int Immunopharmacol; 2003 Apr; 3(4):523-39. PubMed ID: 12689657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The anti-IgE antibody omalizumab as a probe to investigate the role of IgE in pathology.
    Mauro M; Incorvaia C; Formigoni C; Elia R; Russello M; Pellegrino D
    Panminerva Med; 2012 Dec; 54(4):305-12. PubMed ID: 23123583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of taraxasterol on ovalbumin-induced allergic asthma in mice.
    Liu J; Xiong H; Cheng Y; Cui C; Zhang X; Xu L; Zhang X
    J Ethnopharmacol; 2013 Jul; 148(3):787-93. PubMed ID: 23727181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cytokines and allergic response].
    Guenounou M
    Ann Biol Clin (Paris); 1998; 56(3):297-304. PubMed ID: 9754262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A bacterial extract of OM-85 Broncho-Vaxom prevents allergic rhinitis in mice.
    Han L; Zheng CP; Sun YQ; Xu G; Wen W; Fu QL
    Am J Rhinol Allergy; 2014; 28(2):110-6. PubMed ID: 24717947
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Strategies for targeting T-cells in allergic diseases and asthma.
    Heijink IH; Van Oosterhout AJ
    Pharmacol Ther; 2006 Nov; 112(2):489-500. PubMed ID: 16814862
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Role of monoclonal anti-IgE antibodies (rhu-MAb) in the treatment of allergic bronchial asthma].
    Targowski T; From S
    Pol Merkur Lekarski; 2003 Jan; 14(79):65-8. PubMed ID: 12712834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-IgE in the treatment of allergic disorders in pediatrics.
    Fried AJ; Oettgen HC
    Curr Opin Pediatr; 2010 Dec; 22(6):758-64. PubMed ID: 20966754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SOCS proteins in T helper cell differentiation: implications for allergic disorders?
    Inoue H; Kubo M
    Expert Rev Mol Med; 2004 Oct; 6(22):1-11. PubMed ID: 15494080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
    Heinisch IV; Bizer C; Volgger W; Simon HU
    J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular mechanisms of allergic disease.
    Venarske D; deShazo RD
    South Med J; 2003 Nov; 96(11):1049-54. PubMed ID: 14632350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural and clinical impact of anti-allergy agents: An overview.
    Kapoor Y; Kumar K
    Bioorg Chem; 2020 Jan; 94():103351. PubMed ID: 31668464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mediators of the homeostasis and effector functions of memory Th2 cells as novel drug targets in intractable chronic allergic diseases.
    Yeon SM; Choi A; Hong MS; Jung YW
    Arch Pharm Res; 2019 Sep; 42(9):754-765. PubMed ID: 31049823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders.
    Boyman O; Kaegi C; Akdis M; Bavbek S; Bossios A; Chatzipetrou A; Eiwegger T; Firinu D; Harr T; Knol E; Matucci A; Palomares O; Schmidt-Weber C; Simon HU; Steiner UC; Vultaggio A; Akdis CA; Spertini F
    Allergy; 2015 Jul; 70(7):727-54. PubMed ID: 25819018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.